Literature DB >> 19424030

Upregulation of CD59: potential mechanism of accommodation in a large animal model.

Adam D Griesemer1, Masayoshi Okumi, Akira Shimizu, Shannon Moran, Yoshinori Ishikawa, Justin Iorio, J Scott Arn, Kazuhiko Yamada.   

Abstract

BACKGROUND: Survival of ABO-mismatched kidneys with stable renal function despite the persistence of anti-ABO antibodies is called accommodation. The mechanism of accommodation is unclear, but may involve complement regulatory proteins such as CD59. The development of alpha-1,3-galactosyltransferase knock-out (GalT-KO) swine that produce anti-Gal antibodies provides a large animal model capable of determining the role of complement regulatory proteins in accommodation.
METHODS: ELISA and antibody fluorescence-activated cell sorting were used to examine the rate of anti-Gal antibody expression as a function of age. Major histocompatibility complex-matched kidneys were transplanted from Gal-positive MGH miniature swine to MGH GalT-KO swine with systemic immunosuppression. One recipient underwent adsorbtion of anti-Gal antibodies before transplantation. Graft survival, antibody, and complement deposition patterns and CD59 expression were determined.
RESULTS: Three animals rejected Gal-positive kidneys by humoral mechanisms. One animal with low titers of anti-Gal antibody displayed spontaneous accommodation and the animal that was treated with antibody adsorbtion also displayed accommodation. Rejected grafts had deposition of IgM, IgG, C3, and C5b-9 with low expression of CD59, whereas accommodated grafts had low deposition of C5b-9 and high expression of CD59. Retransplantation of one accommodated graft to a naïve GalT-KO animal confirmed that changes in the graft were responsible for the lack of C5b-9 deposition.
CONCLUSION: GalT-KO miniature swine produce anti-Gal antibodies and titers increase with age. These anti-Gal antibodies can cause rejection of major histocompatibility complex-matched kidneys unless accommodation occurs. CD59 up-regulation seems to be involved in the mechanism of accommodation by preventing the formation of the membrane attack complex (MAC) on the accommodated graft.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19424030      PMCID: PMC2772119          DOI: 10.1097/TP.0b013e3181a19afc

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  39 in total

Review 1.  Transplantation of discordant xenografts: a review of progress.

Authors:  J L Platt; G M Vercellotti; A P Dalmasso; A J Matas; R M Bolman; J S Najarian; F H Bach
Journal:  Immunol Today       Date:  1990-12

Review 2.  Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster.

Authors:  M K Liszewski; T W Post; J P Atkinson
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

Review 3.  The renal allograft biopsy.

Authors:  R B Colvin
Journal:  Kidney Int       Date:  1996-09       Impact factor: 10.612

Review 4.  Tolerance to primarily vascularized allografts in miniature swine.

Authors:  P Gianello; J M Fishbein; D H Sachs
Journal:  Immunol Rev       Date:  1993-06       Impact factor: 12.988

5.  Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column.

Authors:  Y Xu; T Lorf; T Sablinski; P Gianello; M Bailin; R Monroy; T Kozlowski; M Awwad; D K Cooper; D H Sachs
Journal:  Transplantation       Date:  1998-01-27       Impact factor: 4.939

6.  Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage.

Authors:  G W Byrne; K R McCurry; M J Martin; S M McClellan; J L Platt; J S Logan
Journal:  Transplantation       Date:  1997-01-15       Impact factor: 4.939

7.  The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells.

Authors:  I A Rooney; A Davies; D Griffiths; J D Williams; M Davies; S Meri; P J Lachmann; B P Morgan
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

8.  Role of the thymus in transplantation tolerance in miniature swine. I. Requirement of the thymus for rapid and stable induction of tolerance to class I-mismatched renal allografts.

Authors:  K Yamada; P R Gianello; F L Ierino; T Lorf; A Shimizu; S Meehan; R B Colvin; D H Sachs
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

9.  Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.

Authors:  W L Fodor; B L Williams; L A Matis; J A Madri; S A Rollins; J W Knight; W Velander; S P Squinto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model.

Authors:  T J Kroshus; R M Bolman; A P Dalmasso; S A Rollins; E R Guilmette; B L Williams; S P Squinto; W L Fodor
Journal:  Transplantation       Date:  1996-05-27       Impact factor: 4.939

View more
  13 in total

Review 1.  The role of complement in the early immune response to transplantation.

Authors:  Steven H Sacks; Wuding Zhou
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

2.  Anti-gal antibodies in α1,3-galactosyltransferase gene-knockout pigs.

Authors:  Jason Fang; Anneke Walters; Hidetaka Hara; Cassandra Long; Peter Yeh; David Ayares; David K C Cooper; John Bianchi
Journal:  Xenotransplantation       Date:  2012-09-13       Impact factor: 3.907

Review 3.  Accommodation in renal transplantation: unanswered questions.

Authors:  Raymond J Lynch; Jeffrey L Platt
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

Review 4.  Complement in organ transplantation.

Authors:  Elham Asgari; Wuding Zhou; Steven Sacks
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

Review 5.  Complement and Transplantation: From New Mechanisms to Potential Biomarkers and Novel Treatment Strategies.

Authors:  Julian K Horwitz; Nicholas H Chun; Peter S Heeger
Journal:  Clin Lab Med       Date:  2018-12-20       Impact factor: 1.935

Review 6.  Xenotransplantation: immunological hurdles and progress toward tolerance.

Authors:  Adam Griesemer; Kazuhiko Yamada; Megan Sykes
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

7.  ABO Incompatible Kidney Transplantation-Current Status and Uncertainties.

Authors:  Milljae Shin; Sung-Joo Kim
Journal:  J Transplant       Date:  2011-12-10

8.  Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes following Lung Transplantation.

Authors:  Laura A Michielsen; Kevin Budding; Daniël Drop; Ed A van de Graaf; Tineke Kardol-Hoefnagel; Marianne C Verhaar; Arjan D van Zuilen; Henny G Otten
Journal:  Front Immunol       Date:  2018-01-22       Impact factor: 7.561

Review 9.  The innate immune system and transplantation.

Authors:  Conrad A Farrar; Jerzy W Kupiec-Weglinski; Steven H Sacks
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

10.  Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome.

Authors:  Laura A Michielsen; Arjan D van Zuilen; Tineke Kardol-Hoefnagel; Marianne C Verhaar; Henny G Otten
Journal:  Front Immunol       Date:  2018-05-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.